Increased stroke risk in childhood cancer survivors

Share :
Published: 15 Apr 2019
Views: 1378
Rating:
Save
Dr Yadav Sapkota - St. Jude Children's Research Hospital, Memphis, USA

Dr Yadav Sapkota speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about the results from the study that performed a genetic analysis on childhood cancer survivors who had received cranial radiation.

Dr Sapkota describes the potential role of genetic predisposition in the development of strokes in childhood cancer survivors.

He also reports the examination of whole genome sequencing data from a cohort of survivors in a retrospective study, and the identification of a chromosomal locus on chromosome 5; which was strongly associated with an increased risk of stroke.

Dr Sapkota believes the discovery of this risk allele will help identify the population that are most at risk of developing strokes and will aid in the development of therapeutic interventions for these survivors.

 

Related Videos

A reproducibility study in pulmonary adenocarcinomas supports a revised classification

Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands
A reproducibility study in pulmonary adenocarcinomas supports a revised classification ( Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands )
12 Sep 2023

Advancing breast cancer treatment in Uganda by improving molecular testing

Dr Jackson Orem - Uganda Cancer Institute, Kampala, Uganda
Advancing breast cancer treatment in Uganda by improving molecular testing ( Dr Jackson Orem - Uganda Cancer Institute, Kampala, Uganda )
8 Jun 2023

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours

Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours ( Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK )
10 May 2023

Targeting BRAF V600E in metastatic colorectal cancer: where are we today?

Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )
9 May 2023

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC

Dr Alberto Servetto - University of Naples Federico II, Naples, Italy
Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC ( Dr Alberto Servetto - University of Naples Federico II, Naples, Italy )
5 Apr 2023

Lung cancer screening and treatment in the Philippines

Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines
Lung cancer screening and treatment in the Philippines ( Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines )
4 Apr 2023

SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023